跳至主要内容
临床试验/NCT04595435
NCT04595435进行中(未招募)不适用

Prospective Registry of Intraoperative Radiation Therapy Using Low Energy X-ray for Breast Cancer at Medical Center, Navicent Health

Wake Forest University Health Sciences1 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2019年3月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
94
试验地点
1
主要终点
Rate of recurrence

研究概览

简要总结

Intraoperative Breast Radiation Therapy (IORT-Breast) utilizing the Xoft Axxent Electronic Brachytherapy System (Xoft) has been recently introduced as a treatment option for women 50 years of age and older who have early stage, low risk Invasive Breast Cancer (IBC). Clinical trials have shown IORT to be non-inferior to whole breast radiation, however some concern continues with rates of recurrence and clinical outcomes.

Given the recent introduction and continued debate it is an excellent opportunity to observe and monitor outcomes in the patients that are treated at Navicent Health through this prospective, observational registry. The opportunity also permits examination of the participant's thoughts and feeling on Quality of Life and Cosmetic Appearance

详细描述

Objectives: (primary and important secondary objectives) The primary objective is to determine rates of recurrence at 5, and 10 years following IORT-Breast at Navicent Health.

Secondary objectives include determination of acute and late effects of IORT-Breast at the treatment site, cosmetic outcomes and satisfaction over 10 years.

In addition, the study will determine why patients who were scheduled for IORT-Breast did not receive it after lumpectomy.

Study Design:

Prospective, observational registry.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Signed informed consent and HIPAA authorization
  • T1 tumor (less than or equal to 20mm in greatest diameter)
  • Histological Grade 1 or 2
  • Node Negative
  • HER-2 -ve

排除标准

  • Previous radiation therapy to the involved breast other than IORT within 6 months
  • High grade tumors (Histologic grade 3)
  • Her-2 Positive
  • Lymphovascular invasion
  • Metastatic disease
  • close proximity to or involvement of skin
  • Multifocal cancer

研究组 & 干预措施

Cohort B- Postoperative Prospective

Subjects who have had IORT performed within the previous 6 month who agree to participate.

干预措施: Lumpectomy (Procedure)

Cohort A- Preoperative Prospective

Subjects are eligible to receive IORT and have agreed to participate in the study prior to any intervention.

干预措施: Lumpectomy (Procedure)

Cohort A- Preoperative Prospective

Subjects are eligible to receive IORT and have agreed to participate in the study prior to any intervention.

干预措施: Intraoperative Radiation Therapy (Radiation)

Cohort B- Postoperative Prospective

Subjects who have had IORT performed within the previous 6 month who agree to participate.

干预措施: Intraoperative Radiation Therapy (Radiation)

结局指标

主要结局

Rate of recurrence

时间窗: 10 year

To determine rate of recurrence of disease at specific time period

Rate of recurrence

时间窗: 5 year

To determine rate of recurrence of disease at specific time period

次要结局

  • Treatment Abandonment(5 years)
  • Acute and late effects(5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验